Literature DB >> 16175384

Classification of parietal pleural invasion at adhesion sites with surgical specimens of lung cancer and implications for prognosis.

Yukitoshi Satoh1, Yuichi Ishikawa, Kentaro Inamura, Sakae Okumura, Ken Nakagawa, Eiju Tsuchiya.   

Abstract

Parietal pleural invasion of non-small cell lung cancer (NSCLC) is a factor for poor prognosis, and a tumor of any size that invades the parietal pleura is classified as T3. However, with microscopic invasion beyond elastic fibers of the visceral pleura but no penetration to the parietal pleura at tight adhesion sites (we term this p1-3), classification as to the T factor is unclear. Among 1,179 consecutive patients with NSCLCs who underwent curative surgery between 1980 and 2002, 20 were in this category. Here, a comparison was made with subgroups of p stages IB, II, and IIIA with regard to histology, pleural invasion, and survival rates. To maximize the power of assessing prognostic potential, we set the significance level at 0.10, one-sided. The p1-3 condition sites of the 20 cases were the parietal pleura for 17 cases and the pericardium, diaphragm, and chest wall for one each of the remainder. The 5-year survival rate for these p1-3 patients was 71.6%. Significant differences were observed between p1-3 and IIIA groups. Although the 5-year survival rates did not significantly differ between p1-3 and T3N0 or unequivocal T3 subgroups, the prognosis of p1-3 patients was rather better than that of T3 and identical to T2. It was demonstrated that p1-3 status is not a factor warranting T3 classification for NSCLCs. Considering the prognosis, pathologic p1-3 tumors should be managed as a T2 disease for the present.

Entities:  

Mesh:

Year:  2005        PMID: 16175384     DOI: 10.1007/s00428-005-0031-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  18 in total

1.  Surgical treatment of lung cancer invading the chest wall: results and prognostic factors.

Authors:  P Magdeleinat; M Alifano; C Benbrahem; L Spaggiari; C Porrello; P Puyo; P Levasseur; J F Regnard
Journal:  Ann Thorac Surg       Date:  2001-04       Impact factor: 4.330

2.  Chest wall invasion in non-small cell lung carcinoma: a rationale for en bloc resection.

Authors:  F Facciolo; G Cardillo; M Lopergolo; G Pallone; F Sera; M Martelli
Journal:  J Thorac Cardiovasc Surg       Date:  2001-04       Impact factor: 5.209

Review 3.  Staging: the key to rational management of lung cancer.

Authors:  J D Miller; L A Gorenstein; G A Patterson
Journal:  Ann Thorac Surg       Date:  1992-01       Impact factor: 4.330

4.  Revisions in the International System for Staging Lung Cancer.

Authors:  C F Mountain
Journal:  Chest       Date:  1997-06       Impact factor: 9.410

5.  Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.

Authors:  D Manac'h; M Riquet; J Medioni; F Le Pimpec-Barthes; A Dujon; C Danel
Journal:  Ann Thorac Surg       Date:  2001-04       Impact factor: 4.330

6.  Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications.

Authors:  B C McCaughan; N Martini; M S Bains; P M McCormack
Journal:  J Thorac Cardiovasc Surg       Date:  1985-06       Impact factor: 5.209

Review 7.  The significance of pleural elastica invasion by lung carcinomas.

Authors:  B Gallagher; S J Urbanski
Journal:  Hum Pathol       Date:  1990-05       Impact factor: 3.466

8.  Chest wall involvement by lung cancer: computed tomographic detection and results of operation.

Authors:  G B Ratto; G Piacenza; C Frola; F Musante; I Serrano; R Giua; M Salio; P Jacovoni; S Rovida
Journal:  Ann Thorac Surg       Date:  1991-02       Impact factor: 4.330

9.  Surgery and the management of peripheral lung tumors adherent to the parietal pleura.

Authors:  M Albertucci; T R DeMeester; M Rothberg; J A Hagen; R Santoscoy; T C Smyrk
Journal:  J Thorac Cardiovasc Surg       Date:  1992-01       Impact factor: 5.209

10.  Pleural involvement in stage IIIM0 non-small-cell bronchogenic carcinoma. A need to differentiate subtypes.

Authors:  K S Albain; P C Hoffman; A G Little; J D Bitran; H M Golomb; T R DeMeester; M L Griem; R R Blough; C Skosey
Journal:  Am J Clin Oncol       Date:  1986-06       Impact factor: 2.339

View more
  2 in total

1.  Preoperative assessment of parietal pleural invasion/adhesion of subpleural lung cancer: advantage of software-assisted analysis of 4-dimensional dynamic-ventilation computed tomography.

Authors:  Tsuneo Yamashiro; Hiroshi Moriya; Maho Tsubakimoto; Yukihiro Nagatani; Tatsuya Kimoto; Sadayuki Murayama
Journal:  Eur Radiol       Date:  2019-03-26       Impact factor: 5.315

2.  Multi-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patients.

Authors:  Yunseon Choi; Ik Jae Lee; Chang Young Lee; Jae Ho Cho; Won Hoon Choi; Hong In Yoon; Yun-Han Lee; Chang Geol Lee; Ki Chang Keum; Kyung Young Chung; Seok Jin Haam; Hyo Chae Paik; Kang Kyoo Lee; Sun Rock Moon; Jong-Young Lee; Kyung-Ran Park; Young Suk Kim
Journal:  Radiat Oncol J       Date:  2015-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.